Centre Hospitalier Saint Nazaire — Clinical Trial Site

21 Registered trials

9 Currently recruiting

Organisation

Centre Hospitalier Saint Nazaire

Location

Saint Nazaire Cedex, France

Identifier

ORG-100045113

Address

11 Boulevard Georges Charpak, Bp 414, 44606, France

Departments

Dermatology
Digestive surgery
Emergency
Hématologie
Hematology
Hematology department
Internal Medecine
Medical Oncology
Medical Oncoloy
Neurology
Oncologie
Oncology
Pain medecine specialist
polyvalent medicine and infectious disease
Radiotherapy
Réanimation médico-chirurgicale - Unité de Surveillance Continue (USC)
Service d'hématologie
SMIT

Clinical trials at this site (21)

Search interface

LIDOCRIT : Effect of continuous intravenous LIDOCaine on discomfort in postoperative CRITical care inpatients Pending

2024-517749-15-00 Postoperative critical care 11
Evaluating a Personalized Treatment Strategy for Young Women with Early Breast Cancer Pending

2024-519655-28-00 Premenopausal patients with high-risk HR-positive/HER2- 5
Phase II study of ficerafusp alfa in combination with nivolumab in patients with platinum-refractory head and neck squamous cell carcinoma w… Pending

2025-521437-88-00 head and neck squamous cell carcinoma 4
Phase 3 study comparing ivonescimab alone or ivonescimab with ligufalimab versus pembrolizumab for the first-line treatment of recurrent and… Recruiting

2025-522996-27-00 recurrent and/or metastatic squamous cell carcinoma of 5 2026-05-05
A multi-center phase III randomized study comparing continuous versus fixed duration therapy with Daratumumab, Lenalidomide, and Dexamethaso… Recruiting

2024-511855-16-00 Onco-hematology 5 2019-07-25
IFM2024-06 : A multi-center, open-label, phase 2 randomized study of elranatamab plus lenalidomide versus daratumumab plus lenalidomide as p… Recruiting

2024-517325-43-00 multiple myeloma 4 2025-06-19
Amoxicillin alone versus amoxicillin/clavulanate for community-acquired pneumonia in patients aged 65 years or older, and hospitalized in a … Recruiting

2023-503645-63-00 Patients aged 65 years or older, hospitalized in a non- 5 2024-04-25
A Trial to Learn if Odronextamab Combined with Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined … Recruiting

2022-502113-28-00 Follicular lymphoma 5 2024-02-01
Capsaicin 179 mg patch versus oral Duloxetine in patients with chemotherapy-induced peripheral neuropathy: a phase 3 randomized multicentric… Recruiting

2023-504618-31-00 Chemotherapy induced peripheral neuropathy (CIPN) 5 2023-10-20
RIISC Recruiting

2024-513669-38-00 Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis 5 2023-05-17
Avoid Anticoagulation After IntraCerebral Haemorrhage Recruiting

2024-514094-22-00 Intrecerebral Haemorrhage 5 2019-01-18
PRODIGE 81-FFCD 2101-TRIPLET: Study evaluating the benefit of adding Ipilimumab to the combination of Atezolizumab and Bevacizumab in patien… Ended

2022-501217-31-00 Hepatocellular carcinoma 10 2023-03-09
Dupilumab step-down strategy to maintain remission in adult and adolescents patients with atopic dermatitis: a non-inferiority randomized tr… Ended

2022-501179-23-00 atopic dermatitis 6 2023-03-08
RITUX-PLUS 2 : A phase 3 randomized and double-blind controlled trial comparing the efficacy and safety of rituximab combined with subcutane… Ended

2024-516168-27-00 Adult patients with persistent or chronic immune thromb 5 2022-11-10
Intravenous Immunoglobulin plus oral prednisone or high-dose dexamethasone, for adults with immune thrombocytopenia (ITP) with moderate and … Ended

2024-516403-16-00 Adult patients with immune thrombocytopenia (ITP) with 5 2022-04-07
Randomized trial of avelumab-cetuximab-Radiotherapy versus standards of care in the head and neck cancers Ended

2024-513964-24-00 Squamous cell carcinoma, previously untreated Stage III 5 2017-09-14
Phase III trial of laryngeal preservation comparating chemotherapy followed by radiotherapy to chemotherapy administrated during radiotherap… Ended

2024-513976-16-00 squamous cell carcinomas of the larynx or hypopharynx l 5 2015-06-26
Study of Taxane-Platinum followed by a maintenance with avelumab and cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma… Halted

2023-510559-41-00 Recurrent or Metastatic Squamous Cell Carcinoma of the 4 2025-01-02
Evaluation of the value of perianal infiltration during thermodestruction of hemorrhoidal disease by Radiofrequency (RAFAELO® procedure) Ended

2024-514117-35-00 hemorrhoidal disease 11 2023-01-10
A RANDOMIZED TRIAL TESTING EARLY VERSUS LATE ONSET OF EPO ALFA TREATMENT IN LOWER RISK MDS WITH NON RBC TRANSFUSION DEPENDENT ANEMIA AND WI… Ended

2024-515356-21-00 Adult subject (18 years of age older) with low or inter 5 2018-04-17
Interest of Intra-nodal injection of gentamicin for the treatment of suppurated cat scratch disease's lymphadenitis Ended

2024-512037-32-00 Bartonellosis 5 2017-05-31